End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,360 IDR | +0.74% | +6.67% | -8.72% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- With an expected P/E ratio at 32.5 and 28.12 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3025.7 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.72% | 1.26B | - | ||
+18.92% | 81.04B | C+ | ||
-29.48% | 68.93B | B- | ||
+9.65% | 29.59B | C+ | ||
-0.14% | 17.24B | A- | ||
-9.30% | 16.99B | B | ||
+0.20% | 15.12B | A- | ||
+5.25% | 13.09B | B- | ||
+68.96% | 12B | C+ | ||
-2.88% | 11.94B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HEAL Stock
- Ratings PT Medikaloka Hermina Tbk